The economics of personalised medicine in low and middle income countries

Bookmark and Share
Published: 14 Dec 2017
Views: 2006
Rating:
Save
Prof Sue Horton - University of Waterloo, Waterloo, Canada

Sue Horton speaks to ecancer at EAPM 2017 in Belfast.

She spoke from an economic perspective about the affordability of personalised medicine for low and middle income countries. 

A global alliance is needed to make medicines available for low and middle income countries at affordable prices.

One of the main problems is a lack of data surrounding the economics of diagnostics for these countries.